Use of recombinant human deoxyribonuclease in pediatric intensive care unit – a single-center experience

OBJECTIVE: Dornase alfa (rhDNase) reduces the viscosity of purulent sputum in the lungs. The use in patients with cystic fibrosis (CF) is proven. However, the evidence of its applicability to other conditions is limited. This study aims to present the authors’ experience with the use of rhDNase in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Meireles, Daniel, Fernandes, Sofia Ribeiro, Sarmento, Alzira, Barbosa, Telma, Magalhães, Manuel Ferreira, Ramos, Ana, Fernandes, Paula Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432166/
https://www.ncbi.nlm.nih.gov/pubmed/34495270
http://dx.doi.org/10.1590/1984-0462/2022/40/2020169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432166/
https://www.ncbi.nlm.nih.gov/pubmed/34495270
http://dx.doi.org/10.1590/1984-0462/2022/40/2020169

Ejemplares similares